Author Archives: Dermatology News From Medical News Today

Growth in dormant hair follicles could be restarted by activating pathway

A pathway known for its role in regulating adult stem cells has been shown to be important for hair follicle proliferation, but contrary to previous studies, is not required within hair follicle stem cells for their survival, according to researchers with the Perelman School of Medicine at the University of Pennsylvania.

Cancer mutation likely trigger of scleroderma

Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage.A report on the discovery, published in the Dec. 5 issue of Science, also suggests that a normal immune system is critical for preventing the development of common types of cancer.

Clinical trial tests insecticide-treated underwear to ward off body lice in shelters

Providing insecticide-treated underwear to people in homeless shelters was effective in eliminating body lice infestations, but the effect did not last and resistance to insecticide resistance increased, according to the results of a clinical trial by Samir Benkouiten, M.P.H., of Aix Marseille Université, France, and colleagues.

Highly effective treatment for excessive scars

Plastic and Reconstructive Surgery assembles evidence on laser therapy for scar prevention and treatmentCurrent laser therapy approaches are effective for treating excessive scars resulting from abnormal wound healing, concludes a special topic paper in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons...

Discovery of genomic variant associated with sun sensitivity, freckles

Researchers have identified a genomic variant strongly associated with sensitivity to the sun, brown hair, blue eyes - and freckles. In the study of Icelanders the researchers uncovered an intricate pathway involving the interspersed DNA sequence, or non-coding region, of a gene that is among a few dozen that are associated with human pigmentation traits.

First topical pharmacologic therapy to enter clinical trials for “double chin”

Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.